BREAKING NEWS: New drug approved by the FDA for Duchenne muscular dystrophy. Learn more about this new treatment option.

Medical Educational Resource

We're accelerating the delivery of treatments and cures.

Gene Therapies: Redefining Treatment in Neuromuscular Disease

Activity Snapshot

Activity Type: 
On-Demand Webinar
Release Date: 
Thursday, November 19, 2020
Sponsor Information: 

This Industry Update Webinar is sponsored by Novartis. This program is not sponsored, endorsed, or accredited by MDA.

Faculty

Dr. Jerry R. Mendell, MD
Nationwide Children's Hospital, Columbus Ohio
Activity Overview: 

Novartis Gene Therapies 30-minute IUW “Redefining Treatment in Neuromuscular Disease” that took place live on Thursday, November is now available for on-demand viewing on the MDA Medical Education Hub.